آذرکیوان, آزیتا

موسسه عالی آموزشی و پژوهشی طب انتقال خون- مرکز تحقیقات- درمانگاه تالاسمی، تهران، ایران

[ 1 ] - کاربرد مدل‌های شفایافته در تحلیل بقای بیماری تالاسمی ماژور

Background: Identification of the factors influencing short term and long term survival for patients is one of the important concerns in medical society. With determining the risk factors and also health factors of a disease, valuable information can be obtained. In some cases, such as high rate of censoring, the use of standard survival models for analysis may cause to loss in some of...

[ 2 ] - تحلیل بقاء بیماران تالاسمی ماژور با استفاده مدل های پارامتری و نیمه پارامتری بقاء

Introduction: Thalasemia Major is one of the most common anemia diseases that can be fatal if not promptly diagnosed. The survival analysis of these patients can be an appropriate strategy in determining risk factors for death in these patients. The purpose of this study was to choose the best model to determine the risk factors for death in patients with the thalasemia major using common metho...

[ 3 ] - Survival analysis of thalassemia major patients using Cox, Gompertz proportional hazard and Weibull accelerated failure time models

Background: Thalassemia major (TM) is a severe disease and the most common anemia worldwide. The survival time of the disease and its risk factors are of importance for physicians. The present study was conducted to apply the semi-parametric Cox PH model and use parametric proportional hazards (PH) and accelerated failure time (AFT) models to identify the risk factors related to survival of TM ...

[ 4 ] - هزینه – مطلوبیت درمان بیماران مبتلا به تالاسمی ماژور در ایران

چکیده سابقه و هدف تالاسمی ماژور یک بیماری اتوزومال مغلوب، با عوارض زیاد و مرگ و میر بالا است. امروزه امید به زندگی بیماران تالاسمی ماژور با پیشرفت‌های درمانی به طور قابل توجهی افزایش یافته است در نتیجه بیماران تالاسمی نیازمند مراقبت مادام‌العمر هستند، اما مراقبت از بیماران تالاسمی هزینه‌های زیادی را ایجاد می‏کند، لذا آگاهی از هزینه‏ها و اثربخشی درمان جهت کنترل هزینه‌ها و ارائه درمان‌های کارآ...

[ 5 ] - تحلیل بقای نیمه پارامتری و پارامتری بیماران مبتلا به بتا تالاسمی ماژور

Background: Beta-thalassemia major is a very severe blood disease, its Clinical signs are premature and appear from 3 to 6 months of age. It is one of the most common monogenic diseases in the world and in Iran, and if it is not diagnosed and treated during the first years of life, it will lead to death. In this study, to check the factors affecting the survival of patients with beta-thalassemi...

[ 6 ] - kidd blood group genotyping in alloimmunized thallasemia patients

Abstract Background and Objectives Hemagglutination has limitations in identifying the phenotype of patients who have been recently transfused due to the presence of donor red cells (RBCs) in the patient’s circulation. Kidd blood group is one of the most important blood groups in transfusion medicine and related antibodies are responsible for one third of delayed haemolytic transfusion reactio...